EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice

Mathieu Amand, Philipp Adams, Rafaela Schober, Gilles Iserentant, Jean-Yves Servais, Michel Moutschen, Carole Seguin-Devaux iD

eLife · 2023

DOI: 10.7554/elife.83207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Mathieu Amand und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection and Immunity, Luxembourg Institute of Health, Esch sur Alzette, Luxembourg. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds National de la Recherche Luxembourg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 infection results in the activation of inflammasome that may facilitate viral spread and establishment of viral reservoirs. We evaluated the effects of the caspase-1 inhibitor VX-765 on HIV-1 infection in humanized NSG mice engrafted with human CD34 + hematopoietic stem cells. Expression of caspase-1, NLRP3, and IL-1β was increased in lymph nodes and bone marrow between day 1 and 3 after HIV-1 infection (mean fold change (FC) of 2.08, 3.23, and 6.05, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsMiceHumansAnimalsInflammasomesInterleukin-18Viral LoadT-LymphocytesCD4-Positive T-LymphocytesViral ProteinsSerpinsDipeptidespara-Aminobenzoates

Stichwörter der Autor:innen

HIVanti-inflammatory agentscytokinehiv reservoirsimmunologyinflammasome inhibitorsinflammationmousepyroptosis

Substanzen

InflammasomesInterleukin-18interleukin-1beta-converting enzyme inhibitorViral ProteinsSerpinsbelnacasanDipeptidespara-Aminobenzoates

Autor:innen und Institutionen

  • Department of Infection and Immunity, Luxembourg Institute of Health, Esch sur Alzette, Luxembourg.
  • Department of Infectious Diseases, University of Liège, CHU de Liège, Liège, Belgium.

ORCID-Profile: Carole Seguin-Devaux

Förderung

  • Fonds National de la Recherche Luxembourg

Zitieren

APA

Amand, M., Adams, P., Schober, R., Iserentant, G., Servais, J. Y., Moutschen, M., & Seguin-Devaux, C. (2023). The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice. eLife. https://doi.org/10.7554/elife.83207

Vancouver

Amand M, Adams P, Schober R, Iserentant G, Servais JY, Moutschen M, et al. The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice. eLife. 2023. doi:10.7554/elife.83207

BibTeX
@article{Amand2023,
  author = {Amand, Mathieu and Adams, Philipp and Schober, Rafaela and Iserentant, Gilles and Servais, Jean-Yves and Moutschen, Michel and Seguin-Devaux, Carole},
  title = {The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice},
  journal = {eLife},
  year = {2023},
  doi = {10.7554/elife.83207}
}
Kostenlos starten →